|Vaso Corporation -- USA Stock|| |
USD 0.068 0.002 2.86%
Chairman of the Board
Mr. Simon Srybnik is Chairman of the Board of Vasomedical Inc. since June 23 2010. He was a director since June 2007 and Chairman of the Board since June 2010. He is the Chairman of the Board of Kerns Manufacturing Corporationration and Living Data Technology Corporationration A lifetime entrepreneur and industrialist Mr. Srybnik has founded and managed many companies in various industries including machinery and process equipment aerospace and defense biotechnology and healthcare.
Age: 97 Chairman Since 2010
The company has return on total asset (ROA)
of (2.96) %
which means that it has lost $2.96 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (32.08) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 9.51 M in liabilities with Debt to Equity (D/E) ratio of 100.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vaso Corporation has Current Ratio of 0.78 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
Vasomedical, Inc. operates in the healthcare equipment and information technology industries. Vaso Corporation (VASO) is traded on OTC Market in USA. It is located in NEW YORK, U.S.A and employs 281 people. Vaso is listed under Medical Equipment category by Fama And French industry classification.